Patent hypocrisies of US
American business lobbies are spreading falsehoods about India’s patent policies—and glossing over their double standards
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
Mark Lynas and the demeaning of science
He’s fuzzy on facts and low on science, but the campaigner gets big media support
A pre-emptive strike against Monsanto
American organic farmers are trying to ensure the biotech giant cannot sue them
Dangers ahead at WTO
The trade facilitation agreement paves the way for fresh pressures on developing countries such as tariff cuts on industrial products
A lethal secrecy in trade deals
Why do democratic governments hide trade negotiations that have dire consequences for public services?
Pursuing a nationalist IPR policy
India has enough laws to protect its intellectual property rights. It is the implementation that is wanting
The pirates come ashore
German Pirate Party’s strong showing in the May elections is a sign that anti-IPR movements resonate with the people
Bringing Google to book
Google’s digital library project went too far, creating a monopoly over the heritage of books
The curious case of Ebola patents
The US government appears to have a cure and (almost) a vaccine for the deadly disease
Biosafety issues get a push
Experts to study socio-economic aspects of GMO release
Industry paid for IP seminars to train judges
Microsoft and Indian Music Industry funded FICCI to hold roundtable for Maharashtra judiciary; judges handling piracy cases special invitees
Whose homeland security?
Nuclear fault lines run deep
Secrecy, fettered regulator are a worry as India plans nuclear expansion
Patent issues delaying Ebola cure
Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine
ACTA fury goes viral
Europe is on the boil over an anti-piracy bill that will curb Internet freedom but its impact on trade in generic medicines is not on the radar
The idea of corruption
Prime Minister’s Logic
Obituary: Ashish Bose, a man who counted
India’s foremost demographer had a lively interest in a host of societal issues, specially the state of the aam aadmi
Big pharma’s dirty tricks
Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India
Disclosure-shy industry
Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues
New endosulfan ploy
Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
How MEA torpedoed the Bangladesh-India gas pipeline
Mani Shankar Aiyar is known for the many controversies sparked by his provocative comments and controversial ideas. As minister for petroleum and …
Bill will push PDS reform
Development economist JEAN DREZE, known for his work on issues such as hunger, famine, social and human development in India, child health and …